Curated and Structure-Based Drug-Target Interactions Improve Underprediction of Drug Side Effects in Network Models

Uncovering New Therapeutic Targets for Amyotrophic Lateral Sclerosis and Neurological Diseases Using Real-World Data

Tensor modeling of MRSA bacteremia cytokine and transcriptional patterns reveals coordinated, outcome-associated immunological programs

Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients’ blood

A multivalent binding model infers antibody Fc species from systems serology

Social interactions do not affect mycoplasma infection in griffon vultures

Nature-inspired design principles promote supply network resilience